tiprankstipranks
Advertisement
Advertisement

Nuwellis Board Directors Resign Amid Governance Dispute

Story Highlights
  • On March 26, 2026, two Nuwellis directors resigned after alleging the company withheld critical information.
  • Nuwellis disputes the directors’ claims and cut its board from seven to five members on March 27, 2026, reshaping governance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Nuwellis Board Directors Resign Amid Governance Dispute

Claim 55% Off TipRanks

Nuwellis ( (NUWE) ) just unveiled an announcement.

On March 26, 2026, Nuwellis directors Mika Grasso and Katharyn Field resigned from the Board effective immediately, citing in their letters various disagreements with the company, including alleged failures by Nuwellis and its advisers to provide them with timely information they say is necessary to fulfill their board duties. The company and remaining directors dispute the allegations, characterize the letters as containing errors and misleading interpretations, and, following the resignations, the Board voted on March 27, 2026, to shrink its size from seven to five members, signaling a tightened governance structure amid a public dispute that may raise concerns among investors about internal oversight and board-management relations.

The most recent analyst rating on (NUWE) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on Nuwellis stock, see the NUWE Stock Forecast page.

Spark’s Take on NUWE Stock

According to Spark, TipRanks’ AI Analyst, NUWE is a Neutral.

The score is weighed down primarily by weak financial performance—ongoing large losses and negative free cash flow with tight liquidity—alongside bearish technical trends. Offsetting factors include strong/expanding gross margins and constructive operational priorities from the earnings call, but execution and funding risks remain prominent.

To see Spark’s full report on NUWE stock, click here.

More about Nuwellis

Nuwellis, Inc. operates in the medical technology sector, though this disclosure does not reiterate its specific products or market focus. The company is publicly traded and subject to U.S. Securities and Exchange Commission reporting requirements, with governance overseen by a Board of Directors whose composition is material to shareholders and regulators.

Average Trading Volume: 2,153,249

Technical Sentiment Signal: Sell

Current Market Cap: $2.54M

Find detailed analytics on NUWE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1